synthetic glycolipid prevents autoimmune encephalomyelitis inducing th2 bias natural killer t cells 
experimental autoimmune encephalomyelitis eae prototype autoimmune disease mediated type helper t th1 cells control regulatory cells1- report synthetic glycolipid ligand cd1d-restricted natural killer t nkt cells expressing semi-invariant t-cell receptor v alpha + preventive eae ligand analogue alpha galactosylceramide alpha gc prototype nkt cell ligand truncated sphingosine chain alpha gc causes nkt cells produce interferon ifn-gamma interleukin il- refs however new ligand can induce predominant production il- nkt cells single injection glycolipid alpha gc consistently induced th2 bias autoimmune t cells causing nkt cells produce il- leading suppression eae lack polymorphism cd1d cross-reactive response mouse human nkt cells ligand6 indicates targeting nkt cells ligand may attractive means intervening human autoimmune diseases multiple sclerosis 
